Whitehawk Therapeutics (WHWK) Payables (2018 - 2025)
Historic Payables for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $1.6 million.
- Whitehawk Therapeutics' Payables rose 1885.01% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 1885.01%. This contributed to the annual value of $2.2 million for FY2024, which is 6339.44% down from last year.
- Per Whitehawk Therapeutics' latest filing, its Payables stood at $1.6 million for Q3 2025, which was up 1885.01% from $3.3 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Payables high stood at $6.5 million for Q1 2023, and its period low was $1.4 million during Q3 2024.
- In the last 5 years, Whitehawk Therapeutics' Payables had a median value of $3.3 million in 2025 and averaged $3.5 million.
- As far as peak fluctuations go, Whitehawk Therapeutics' Payables skyrocketed by 11533.43% in 2021, and later crashed by 6339.44% in 2024.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' Payables stood at $6.4 million in 2021, then tumbled by 45.35% to $3.5 million in 2022, then soared by 67.6% to $5.9 million in 2023, then crashed by 63.39% to $2.2 million in 2024, then decreased by 24.36% to $1.6 million in 2025.
- Its Payables was $1.6 million in Q3 2025, compared to $3.3 million in Q2 2025 and $3.7 million in Q1 2025.